Sander Timmer
  • Home
  • Networks
  • My Projects
  •  Blog
  • Contact
Sander Timmer Global Head of Data Science and AI for Global Drug Development at Novartis
Networks

Networks

Follow me on LinkedIn.

Follow me on Twitter.

Recent Posts

  • Beyond Human Performance: Multi-Agent AI for GxP-Compliant Pharma Manufacturing
  • New Chapter: Leading AI & Data Science in Global Drug Development at Novartis
  • GSK Case Study: Building a Registry of Truth for Global AI Ops
  • Speaking at Weights & Biases Fully Connected: The Era of Physical AI
  • Databricks Data & AI summit speaker

Sander Timmer, PhD, is the Global Head of Data Science and AI for Global Drug Development at Novartis. He has over 15 years of experience delivering production AI systems in life sciences. Previously, he led AI engineering and decision sciences at GSK and served as an AI strategy leader at Microsoft.

Sander Timmer, PhD, is the Global Head of Data Science and AI for Global Drug Development at Novartis. He has over 15 years of experience delivering production AI systems in life sciences. Previously, he led AI engineering and decision sciences at GSK and served as an AI strategy leader at Microsoft.

Recent Posts

  • Beyond Human Performance: Multi-Agent AI for GxP-Compliant Pharma Manufacturing
  • New Chapter: Leading AI & Data Science in Global Drug Development at Novartis
  • GSK Case Study: Building a Registry of Truth for Global AI Ops
  • Speaking at Weights & Biases Fully Connected: The Era of Physical AI
  • Databricks Data & AI summit speaker

About me

I am a Lead Data Scientist at Microsoft in the World-Wide Data Insights CTO office focusing on cloud solutions for the Internet-of-Things, Big Data, Deep Learning, and Machine Learning. I obtained my PhD at the University of Cambridge specialising in Big Data Biology while being based at the European Bioinformatics Institute (EBI) and the European Molecular Biology Laboratory (EMBL).

In my previous "academic life", I was working in Ewan Birney's research group. My main subject was understanding non-coding variation using genome-wide molecular assays, like FAIRE and CTCF, onto Human cell line populations. Another research interest was identification of whole-body phenotypes in Human MRI scans using Machine Learning techniques.

Furthermore, I'm the co-founder of Rijschoolvergelijker. The largest driving school comparison website in the Netherlands with European ambitions.

Recent posts

  • Beyond Human Performance: Multi-Agent AI for GxP-Compliant Pharma Manufacturing
  • New Chapter: Leading AI & Data Science in Global Drug Development at Novartis
  • GSK Case Study: Building a Registry of Truth for Global AI Ops
  • Speaking at Weights & Biases Fully Connected: The Era of Physical AI
  • Databricks Data & AI summit speaker
© 2026 Sander Timmer | Powered by Outstandingthemes